Blood test may predict rate of Alzheimer's
(sphingomyelins and ceramides)
(sphingomyelins and ceramides)
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
DONATE NOW\
Researchers from Johns Hopkins University reported they may be able to predict how quickly patients with Alzheimer’s will lose cognitive function by looking at levels of certain fats in the blood.
The finding could provide useful information to families and caregivers and may also suggest treatment targets for the neurodegenerative disorder.
Past research has shown that cognitive function declines at different rates in Alzheimer’s patients. One-third of patients do not decline at all in five years time, another third decline at a moderate rate, and the remaining patients decline relatively quickly. Continue to read: foxnews.com 
Nonocular and ocular hemorrhages with aspirin use
The studies highlight the risk of intraocular hemorrhages in patients with wAMD taking aspirin. In view of these concerns, the authors considered it important to present their results to the scientific and clinical community to draw attention to the possible adverse effect of aspirin on AMD and to stimulate other studies with data on aspirin use and AMD to investigate these effects. Read more: sciencedirect.com